Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus

Código QR

Effects of Metformin on the Gut Microbiota in Obesity and Type 2 Diabetes Mellitus

Qi Zhang,1 Nan Hu2 1Department of Pharmacy, Changzhou No.7 People’s Hospital, Changzhou 213000, People’s Republic of China; 2Department of Pharmacy, The Third Affiliated Hospital of Soochow University, Changzhou 213000, People’s Republic of ChinaCorrespondence: Nan HuDe...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Zhang Q, Hu N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	metformin gut microbiota obesity type 2 diabetes mellitus Specialties of internal medicine RC581-951
Acceso en línea:	https://doaj.org/article/e8064fb5a1f343d5bc59da3837413ef2
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus
por: Jevtovic F
Publicado: (2021)

The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2
por: Elena V. Pokrovskaya, et al.
Publicado: (2019)

The Profile and Function of Gut Microbiota in Diabetic Nephropathy
por: Chen W, et al.
Publicado: (2021)

Do we need to measure vitamin B12 and magnesium in morbidly obese patients with type 2 diabetes mellitus?
por: Wåhlén A, et al.
Publicado: (2017)

Incidence and Survival of Hepatocellular Carcinoma in Type 2 Diabetes Patients with Cirrhosis Who Were Treated with and without Metformin
por: Tangjarusritaratorn T, et al.
Publicado: (2021)

Efficacy and safety of metformin-sitagliptin combination for the treatment of patients with diabetes mellitus and obesity
por: Alexander Sergeevich Ametov, et al.
Publicado: (2010)

Prospects for the use of fecal microbiota transplantation in obese patients with Type 2 Diabetes Mellitus for weight loss and improvement of insulin sensitivity
por: E. V. Pokrovskaya, et al.
Publicado: (2021)

Nutritional Effects of the Enteral Nutritional Formula on Regulation of Gut Microbiota and Metabolic Level in Type 2 Diabetes Mellitus Mice
por: Wei T, et al.
Publicado: (2021)

Metformin action over gut microbiota is related to weight and glycemic control in gestational diabetes mellitus: A randomized trial
por: María Molina-Vega, et al.
Publicado: (2022)

Corrigendum: The new views on the state of the gut microbiota in obesity and diabetes mellitus type 2 (Diabetes mellitus. 2019;22(3). doi: 10.14341/DM10194)
por: Elena V. Pokrovskaya, et al.
Publicado: (2019)

Effect of Metformin or Chinese Herbal Formula in Patients with Type 2 Diabetes Mellitus and Hyperlipidemia: A Reassessment
por: Venu Gopal Jonnalagadda, et al.
Publicado: (2018)

Modulation of fat metabolism and gut microbiota by resveratrol on high-fat diet-induced obese mice
por: Campbell CL, et al.
Publicado: (2019)

Phocea, Pseudoflavonifractor and Lactobacillus intestinalis: Three Potential Biomarkers of Gut Microbiota That Affect Progression and Complications of Obesity-Induced Type 2 Diabetes Mellitus
por: Wang Y, et al.
Publicado: (2020)

Assessment of Serum Vitamin B12 and Folate Levels and Macrocytosis in Patients with Type 2 Diabetes Mellitus on Metformin Attending Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: A Cross-Sectional Study
por: Wale Tesega W, et al.
Publicado: (2021)

Effect of Metformin on Breast Density in Overweight/Obese Premenopausal Women
por: Leng W, et al.
Publicado: (2021)

Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial
por: Xiaolin Tong, et al.
Publicado: (2018)

Difference in Gut Microbiota between the First and the Second Trimester of Pregnancy and the Association of Gut Microbiota with Gestational Diabetes Mellitus: A Prospective Cohort Study
por: WANG Pei, et al.
Publicado: (2021)

Short-term efficacy and safety of repaglinide versus glimepiride as augmentation of metformin in treating patients with type 2 diabetes mellitus
por: Xie J, et al.
Publicado: (2019)

Patient considerations in type 2 diabetes – role of combination dapagliflozin–metformin XR
por: Kuecker CM, et al.
Publicado: (2016)

Obesity, Insulin Resistance, and Type 2 Diabetes: Associations and Therapeutic Implications
por: Wondmkun YT
Publicado: (2020)

“Adjusting Internal Organs and Dredging Channel” Electroacupuncture Ameliorates Insulin Resistance in Type 2 Diabetes Mellitus by Regulating the Intestinal Flora and Inhibiting Inflammation
por: Zhang L, et al.
Publicado: (2021)

Correlation Between Circulating Levels of Secreted Frizzled-Related Protein 5 and Type 2 Diabetic Patients and Subjects with Impaired-Glucose Regulation
por: He X, et al.
Publicado: (2020)

Neudesin in obesity and type 2 diabetes mellitus: the effect of acute fasting and weight reducing interventions
por: Kratochvilova H, et al.
Publicado: (2019)

Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
por: Hassoun AAK, et al.
Publicado: (2016)

Repaglinide/metformin fixed-dose combination to improve glycemic control in patients with type 2 diabetes: an update
por: Moses R
Publicado: (2010)

Unique Habitual Food Intakes in the Gut Microbiota Cluster Associated with Type 2 Diabetes Mellitus
por: Yuriko Kondo, et al.
Publicado: (2021)

Metformin and Malignant Tumors: Not Over the Hill
por: Leng W, et al.
Publicado: (2021)

Sarcopenia and type 2 diabetes mellitus: a bidirectional relationship
por: Mesinovic J, et al.
Publicado: (2019)

Characteristics of the Gut Microbiota and Potential Effects of Probiotic Supplements in Individuals with Type 2 Diabetes <i>mellitus</i>
por: Rafael Ballan, et al.
Publicado: (2021)

A Comparison Between the Therapeutic Effect of Metformin Alone versus a Combination Therapy with Insulin in Uncontrolled, Non-Adherence Patients with Type 2 Diabetes: Six Months Follow-Up
por: Paczkowska A, et al.
Publicado: (2021)

Association Between Different Obesity Patterns and the Risk of Developing Type 2 Diabetes Mellitus Among Adults in Eastern China: A Cross-Sectional Study
por: Lu Y, et al.
Publicado: (2021)

The Associations Between Vitamin D Receptor BsmI and ApaI Polymorphisms and Obesity in Korean Patients with Type 2 Diabetes Mellitus
por: Nam SW, et al.
Publicado: (2021)

Modern Understanding of the Gut Microbiotа in Patients with Diabetes Mellitus
por: E. V. Chugunova, et al.
Publicado: (2021)

Acarbose Reduces Low-Grade Albuminuria Compared to Metformin in Chinese Patients with Newly Diagnosed Type 2 Diabetes
por: Song L, et al.
Publicado: (2021)

Natural Ingredients from Medicine Food Homology as Chemopreventive Reagents against Type 2 Diabetes Mellitus by Modulating Gut Microbiota Homoeostasis
por: Xiaoyan Xia, et al.
Publicado: (2021)

Metformin Treatment: A Potential Cause of Megaloblastic Anemia in Patients with Type 2 Diabetes Mellitus
por: Albai O, et al.
Publicado: (2020)

Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia
por: Gebrie D, et al.
Publicado: (2021)

Effects of coenzyme Q10 on cardiovascular and metabolic biomarkers in overweight and obese patients with type 2 diabetes mellitus: a pooled analysis
por: Huang H, et al.
Publicado: (2018)

Association Between Chinese Visceral Adiposity Index and Incident Type 2 Diabetes Mellitus in Japanese Adults
por: Shang L, et al.
Publicado: (2021)

Characteristics of Gut Microbiota in Cerulein-Induced Chronic Pancreatitis
por: Wu C, et al.
Publicado: (2021)